SolarEdge Technologies (NASDAQ:SEDG) -4.2% in Monday's trading after TD Cowen downgraded shares to Hold from Buy with a $16 ...
TD Cowen downgraded SolarEdge Technologies (NASDAQ:SEDG) from Buy to Hold in a research note, citing ongoing challenges in ...
TD Cowen downgraded SolarEdge (SEDG) to Hold from Buy with a price target of $16, down from $35. The firm cites deteriorating demand in Europe for the downgrade. This will delay a volume, margin ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.68% of ...
SolarEdge Technologies (SEDG – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Jeff Osborne from TD Cowen downgraded the rating on the stock to a ...
TD Cowen upgraded CVS Health (NYSE:CVS) to Buy from Hold and raised its price target to $85 from $59 on Friday, citing an attractive risk-reward setup following several updates related to its ...
TD Cowen on Monday upgraded Accenture (NYSE:ACN) to 'buy' with PT of $400, stating that the IT major has reinforced the demand stabilization theme and initial FY25 guide is appropriately ...
Fintel reports that on October 4, 2024, TD Cowen upgraded their outlook for EVgo (NasdaqGS:EVGO) from Hold to Buy. As of September 25, 2024, the average one-year price target for EVgo is $5.66/share.
Ulta Beauty Inc. was downgraded by TD Cowen Monday, with the analyst firm citing the increasing cost of competition for the specialty retailer. “While [Ulta] remains a category leader with a ...
In a note on Monday downgrading their rating of Humana to "Hold" from "Buy", the TD Cowen analysts flagged that "[a]bsent successful appeal efforts, recovery of normalized margins may be pushed ...
Investing.com -- Analysts at TD Cowen have raised their rating of CVS Health (NYSE:CVS) to "Buy" from "Hold", citing changes to its 2025 Medicare Advantage plan benefits announced earlier this week.